ASCLETIS-B (01672) announced that on September 30, 2025, the company granted stock options to 10 participants (grantees) under the stock option scheme adopted by the company on February 3, 2025 (the 2025 Stock Option Scheme). The stock options entitle holders to subscribe for a total of 650,000 ordinary shares of the company, each with a par value of US$0.0001.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.